CP
ICPT

Caligan Partners’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Caligan Partners’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,293,510
Closed -$14.6M – 15
2023
Q2 		$14.3M Buy
+1,293,510
New +$18M 8.05% 5

Caligan Partners's ICPT Position: Q3 2023 in Review

Caligan Partners sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q3 2023, closing a stake of 1,293,510 shares — an estimated $14.6M sold.

Caligan Partners first reported a position in ICPT in Q2 2023 and held it in 1 quarter. The position peaked at $14.3M in Q2 2023. 146 funds tracked by Wall St. Rank hold ICPT as of Q3 2023.

  • Caligan Partners reported no remaining Intercept Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
  • Caligan Partners sold 1,293,510 Intercept Pharmaceuticals, Inc. shares in Q3 2023, an estimated $14.6M.
  • Caligan Partners first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2023 and held it in 1 quarter.
  • Caligan Partners's Intercept Pharmaceuticals, Inc. position peaked at $14.3M in Q2 2023.
  • 146 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q3 2023.

Based on Caligan Partners's 13F filing for Q3 2023, filed 14 Nov 2023.